Pulmonary Hypertension--Mechanisms and Family Registry
NCT00005357 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2016-02-10
Summary
To establish a registry of primary pulmonary hypertension (PPH), a lethal disease which causes progressive obstruction of small pulmonary arteries and to investigate basic mechanisms of the disease.
Conditions
- Lung Diseases
- Hypertension, Pulmonary
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
collaborator NIH -
Vanderbilt University
lead OTHER
Principal Investigators
-
James Loyd · Vanderbilt University
Eligibility
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1994-04-30
- Primary Completion
- 1999-03-31
- Completion
- 1999-03-31
More Related Trials
-
Novel Index (PIMR) in PAH
NCT05812976 ·Status: COMPLETED
-
The Effects of Pulmonary Hypertension Web-Based Health Care Program on Symptom Management, Social Support, Activity Tolerance, and Quality of Life in Patients With Pulmonary Hypertension.
NCT05908019 ·Status: UNKNOWN ·Phase: NA
-
Feasibility of Slow-paced Respiration Therapy for Treatment of a Symptom Cluster in Pulmonary Arterial Hypertension
NCT02080533 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pediatric Pulmonary Hypertension Network (PPHNet) Informatics Registry
NCT02249923 ·Status: RECRUITING
-
Clinical Profile of Patients With Pulmonary Hypertension Due to Lung Diseases ( Single Center Experience)
NCT02774928 ·Status: UNKNOWN
-
Pharmacogenomics in Pulmonary Arterial Hypertension
NCT00593905 ·Status: WITHDRAWN
-
What is the Role of the Exposome in Pulmonary Hypertension
NCT07172334 ·Status: NOT_YET_RECRUITING
-
The PAH Platform for Deep Phenotyping in Korean Subjects
NCT03933579 ·Status: UNKNOWN
-
A Study of Real-world Cohort of Pulmonary Arterial Hypertension (PAH) Participants
NCT04955990 ·Status: TERMINATED ·Phase: PHASE4
-
Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension
NCT02610660 ·Status: COMPLETED
-
Integrated Diagnostics Characterization of Right Ventricular Diastolic Flow Dynamics in Pulmonary Arterial Hypertension
NCT01491646 ·Status: COMPLETED
-
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
NCT06035861 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation of the Pulmonary Vascular Reactivity Test in Patients With Pulmonary Arterial Hypertension and a Cardiac Shunt
NCT02138708 ·Status: WITHDRAWN ·Phase: NA
-
Study Performed at Various Medical Centers to Learn More About Survival and Expected Course of Pulmonary Arterial Hypertension, a Type of High Blood Pressure in the Lungs Related to the Narrowing of the Small Blood Vessels in the Lungs
NCT03863990 ·Status: COMPLETED
-
Noninvasive Cardiac Output Measurements in Patients With Pulmonary Hypertension Undergoing Right Heart Catheterization With Acute Vasodilator Testing
NCT01275690 ·Status: WITHDRAWN
-
Assessing the Utility of Submaximal CPET in Treatment Management of PAH
NCT05977933 ·Status: NOT_YET_RECRUITING
-
Telemonitoring to Treat Group 2 Pulmonary Hypertension
NCT04882774 ·Status: WITHDRAWN ·Phase: PHASE2
-
Patient Reported Outcomes in Pulmonary Arterial Hypertension
NCT01792622 ·Status: WITHDRAWN
-
REVEAL Registry™: Registry to Evaluate Early And Long-term PAH Disease Management
NCT00370214 ·Status: COMPLETED
-
Retrospective Data Analysis of Data From the Zurich PH Registry
NCT03198910 ·Status: COMPLETED
-
Latin American Pulmonary Hypertension Registry
NCT02570737 ·Status: UNKNOWN
-
Transforming Growth Factor Beta Signalling in the Development of Muscle Weakness in Pulmonary Arterial Hypertension
NCT01847716 ·Status: TERMINATED
-
Epidemiology and Treatment Patterns of Paediatric PAH (Pulmonary Arterial Hypertension)
NCT02576002 ·Status: COMPLETED
-
Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)
NCT04968210 ·Status: COMPLETED
-
Utility of Exercise-induced N-terminal (NT) Pro-brain Natriuretic Peptide Levels in Predicting Prognosis in Asymptomatic Aortic Stenosis
NCT00567437 ·Status: TERMINATED ·Phase: NA